Page last updated: 2024-11-02

phenylmethylsulfonyl fluoride and von Willebrand Diseases

phenylmethylsulfonyl fluoride has been researched along with von Willebrand Diseases in 1 studies

Phenylmethylsulfonyl Fluoride: An enzyme inhibitor that inactivates IRC-50 arvin, subtilisin, and the fatty acid synthetase complex.
phenylmethanesulfonyl fluoride : An acyl fluoride with phenylmethanesulfonyl as the acyl group.

von Willebrand Diseases: Group of hemorrhagic disorders in which the VON WILLEBRAND FACTOR is either quantitatively or qualitatively abnormal. They are usually inherited as an autosomal dominant trait though rare kindreds are autosomal recessive. Symptoms vary depending on severity and disease type but may include prolonged bleeding time, deficiency of factor VIII, and impaired platelet adhesion.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hau, L1
Firkin, BG1
Howard, MA1

Other Studies

1 other study available for phenylmethylsulfonyl fluoride and von Willebrand Diseases

ArticleYear
Binding of human thrombin to human factor VIII:RAg.
    British journal of haematology, 1986, Volume: 62, Issue:3

    Topics: Antigens; Electrophoresis, Agar Gel; Factor VIII; Hemophilia A; Humans; Molecular Weight; Phenylmeth

1986